Témata prací (Výběr práce)Témata prací (Výběr práce)(verze: 368)
Detail práce
   Přihlásit přes CAS
Diagnostika diabetes mellitus
Název práce v jazyce práce (slovenština): Diagnostika diabetes mellitus
Název práce v češtině: Diagnostika diabetes mellitus
Název v anglickém jazyce: Diabetes mellitus diagnostics
Akademický rok vypsání: 2017/2018
Typ práce: bakalářská práce
Jazyk práce: slovenština
Ústav: Katedra biologických a lékařských věd (16-16150)
Vedoucí / školitel: prof. PharmDr. Petr Nachtigal, Ph.D.
Řešitel: skrytý - zadáno vedoucím/školitelem
Datum přihlášení: 24.11.2017
Datum zadání: 16.04.2019
Datum a čas obhajoby: 04.06.2019 08:00
Datum odevzdání elektronické podoby:23.04.2019
Datum proběhlé obhajoby: 04.06.2019
Oponenti: PharmDr. Petra Fikrová, Ph.D.
 
 
 
Zásady pro vypracování
Literární rešerše
Seznam odborné literatury
[1] J. Zhu, Y. Chen, C. Li, M. Tao and Y. Teng, The diagnostic value of glycated albumin in gestational diabetes mellitus, Journal of endocrinological investigation (2017).
[2] Z. Zhao, X. Li, D. Jian, P. Hao, L. Rao and M. Li, Hsa_circ_0054633 in peripheral blood can be used as a diagnostic biomarker of pre-diabetes and type 2 diabetes mellitus, Acta diabetologica 54 (2017) 237-245.
[3] R. Tripathi, D. Verma, V.K. Gupta, S. Tyagi, M. Kalaivani, S. Ramji and Y.M. Mala, Evaluation of 75 g glucose load in non-fasting state [Diabetes in Pregnancy Study group of India (DIPSI) criteria] as a diagnostic test for gestational diabetes mellitus, The Indian journal of medical research 145 (2017) 209-214.
[4] S.E. Spratt, K. Pereira, B.B. Granger, B.C. Batch, M. Phelan, M. Pencina, M.L. Miranda, E. Boulware, J.E. Lucas, C.L. Nelson, B. Neely, B.A. Goldstein, P. Barth, R.L. Richesson, I.L. Riley, L. Corsino, E.R. McPeek Hinz, S. Rusincovitch, J. Green, A.B. Barton, D.D.C.P. Group, C. Kelley, K. Hyland, M. Tang, A. Elliott, E. Ruel, A. Clark, M. Mabrey, K.L. Morrissey, J. Rao, B. Hong, M. Pierre-Louis, K. Kelly and N. Jelesoff, Assessing electronic health record phenotypes against gold-standard diagnostic criteria for diabetes mellitus, Journal of the American Medical Informatics Association : JAMIA 24 (2017) e121-e128.
[5] S. Spiller, Y. Li, M. Bluher, L. Welch and R. Hoffmann, Glycated lysine-141 in haptoglobin improves the diagnostic accuracy for type 2 diabetes mellitus in combination with glycated hemoglobin HbA1c and fasting plasma glucose, Clinical proteomics 14 (2017) 10.
[6] M.P. Sirimarco, H.M. Guerra, E.G. Lisboa, J.M. Vernini, B.N. Cassetari, R.A. de Araujo Costa, M.V. Rudge and I. de Mattos Paranhos Calderon, Diagnostic protocol for gestational diabetes mellitus (GDM) (IADPSG/ADA, 2011): influence on the occurrence of GDM and mild gestational hyperglycemia (MGH) and on the perinatal outcomes, Diabetology & metabolic syndrome 9 (2017) 2.
[7] P. Saxena, P. Verma and B. Goswami, Comparison of Diagnostic Accuracy of Non-fasting DIPSI and HbA1c with Fasting WHO Criteria for Diagnosis of Gestational Diabetes Mellitus, Journal of obstetrics and gynaecology of India 67 (2017) 337-342.
[8] A.L. Pimentel, G. Cavagnolli and J.L. Camargo, Diagnostic accuracy of glycated hemoglobin for post-transplantation diabetes mellitus after kidney transplantation: systematic review and meta-analysis, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 32 (2017) 565-572.
[9] S.D. Pastakia, B. Njuguna, B.A. Onyango, S. Washington, A. Christoffersen-Deb, W.K. Kosgei and P. Saravanan, Prevalence of gestational diabetes mellitus based on various screening strategies in western Kenya: a prospective comparison of point of care diagnostic methods, BMC pregnancy and childbirth 17 (2017) 226.
[10] T. Murata, K. Tsuzaki, S. Nirengi, T. Watanabe, Y. Mizutani, H. Okada, M. Tsukamoto, S. Odori, R. Nakagawachi, Y. Kawaguchi, F. Yoshioka, K. Yamada, A. Shimatsu, K. Kotani, N. Satoh-Asahara and N. Sakane, Diagnostic accuracy of the anti-glutamic acid decarboxylase antibody in type 1 diabetes mellitus: Comparison between radioimmunoassay and enzyme-linked immunosorbent assay, Journal of diabetes investigation 8 (2017) 475-479.
[11] X. Li, Z. Zhao, C. Gao, L. Rao, P. Hao, D. Jian, W. Li, H. Tang and M. Li, The Diagnostic Value of Whole Blood lncRNA ENST00000550337.1 for Pre-Diabetes and Type 2 Diabetes Mellitus, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 125 (2017) 377-383.
[12] S.H. Koning, J.J. van Zanden, K. Hoogenberg, H.L. Lutgers, A.W. Klomp, F.J. Korteweg, A.J. van Loon, B.H.R. Wolffenbuttel and P.P. van den Berg, New diagnostic criteria for gestational diabetes mellitus and their impact on the number of diagnoses and pregnancy outcomes, Diabetologia (2017).
[13] D. Kibirige, D. Atuhe, L. Kampiire, D.S. Kiggundu, P. Donggo, J. Nabbaale, R.M. Mwebaze, R. Kalyesubula and W. Lumu, Access to medicines and diagnostic tests integral in the management of diabetes mellitus and cardiovascular diseases in Uganda: insights from the ACCODAD study, International journal for equity in health 16 (2017) 154.
[14] H. Kalscheuer and H. Lehnert, [Diagnostic Approach to Manifestation of Type 1 Diabetes mellitus], Deutsche medizinische Wochenschrift 142 (2017) 723-730.
[15] X.F. Hu, X.R. Han, Z.Y. Yang, Y.H. Hu and J.L. Tang, [The impact of broadened diagnostic criteria on the prevalence of hypertension, hyperlipidemia and diabetes mellitus in China], Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine] 51 (2017) 369-377.
[16] J. Hu, M. Ye and Z. Zhou, Aptamers: novel diagnostic and therapeutic tools for diabetes mellitus and metabolic diseases, Journal of molecular medicine 95 (2017) 249-256.
[17] F.W. Hanna, C.J. Duff, A. Shelley-Hitchen, E. Hodgson and A.A. Fryer, Diagnosing gestational diabetes mellitus: implications of recent changes in diagnostic criteria and role of glycated haemoglobin (HbA1c), Clinical medicine 17 (2017) 108-113.
[18] Y.L. Cao, Y.J. Jia, B.H. Xing, D.D. Shi and X.J. Dong, Plasma microRNA-16-5p, -17-5p and -20a-5p: Novel diagnostic biomarkers for gestational diabetes mellitus, The journal of obstetrics and gynaecology research 43 (2017) 974-981.
[19] S. Ambachew and B. Biadgo, Hepcidin in Iron Homeostasis: Diagnostic and Therapeutic Implications in Type 2 Diabetes Mellitus Patients, Acta haematologica 138 (2017) 183-193.
[20] S. Adam and P. Rheeder, Screening for gestational diabetes mellitus in a South African population: Prevalence, comparison of diagnostic criteria and the role of risk factors, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 107 (2017) 523-527.
[21] D.N. Voormolen, S.K. Abell, R. James, W.M. Hague and B.W. Mol, Diagnostic Criteria and Treatment for Gestational Diabetes Mellitus, Seminars in reproductive medicine 34 (2016) 102-9.
[22] G.L. van der Zwaan, S.E.M. van Dijk, M.C. Adriaanse, H.W.J. van Marwijk, M.W. van Tulder, A.D. Pols and J.E. Bosmans, Diagnostic accuracy of the Patient Health Questionnaire-9 for assessment of depression in type II diabetes mellitus and/or coronary heart disease in primary care, Journal of affective disorders 190 (2016) 68-74.
[23] K. Smriti, K.M. Pai, V. Ravindranath, S. Gadicherla and K.C. Pentapati, Salivary Glucose as a Diagnostic Marker for Diabetes Mellitus, Journal of diabetes science and technology 10 (2016) 991-992.
[24] P. Sayakhot and M. Carolan-Olah, Sources of information on Gestational Diabetes Mellitus, satisfaction with diagnostic process and information provision, BMC pregnancy and childbirth 16 (2016) 287.
[25] P. Sadlecki, M. Grabiec and M. Walentowicz-Sadlecka, Prenatal Clinical Assessment of NT-proBNP as a Diagnostic Tool for Preeclampsia, Gestational Hypertension and Gestational Diabetes Mellitus, PloS one 11 (2016) e0162957.
[26] S. Park, W. Lee, H.S. Chung and K.S. Hong, Diagnostic Utility of Serum Glycated Albumin for Diabetes Mellitus and Its Correlation With Hyperlipidemia, Annals of laboratory medicine 36 (2016) 306-12.
[27] A.H. Owora, Diagnostic validity and clinical utility of HbA1c tests for Type 2 diabetes mellitus, Current diabetes reviews (2016).
[28] E.P. O'Sullivan, G. Avalos, M.W. O'Reilly, M.C. Dennedy, G. Gaffney, F. Dunne and D.I.P.c. Atlantic, Erratum to: Atlantic Diabetes in Pregnancy (DIP): the prevalence and outcomes of gestational diabetes mellitus using new diagnostic criteria, Diabetologia 59 (2016) 873.
[29] T. Morooka and K. Node, [Diagnostic approach and modalities for coronary artery disease in patients with diabetes mellitus], Nihon rinsho. Japanese journal of clinical medicine 74 Suppl 2 (2016) 306-10.
[30] S.C. Mirescu, R. Pais, B.P. Stanoiu, L. Di Natale and A.S. Sovrea, The value of exfoliative cytology in the diagnostic of oral mucosa changes in diabetes mellitus, Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie 57 (2016) 1313-1322.
[31] B. Larijani, R. Heshmat, M. Ebrahimi-Rad, S. Khatami, S. Valadbeigi and R. Saghiri, Diagnostic Value of Adenosine Deaminase and Its Isoforms in Type II Diabetes Mellitus, Enzyme research 2016 (2016) 9526593.
Předběžná náplň práce
Literární rešerše
 
Univerzita Karlova | Informační systém UK